Cancer places a huge burden on the livelihoods and economies of the European Union. The World Health Organisation estimates that the disease is responsible for 20% of deaths in the region. In 2020, 2.7m people in the EU were diagnosed with cancer and another 1.3m people lost their lives to the disease. The following year the EU launched its “Europe’s Beating Cancer Plan”, a blueprint for how the bloc will tackle and, eventually, eradicate the disease. Within that, each member state is expected to publish its own National Cancer Plan (NCP).

The fifth annual Greece Cancer Summit “Evaluating Europe’s latest cancer strategies”, produced by Economist Impact and Hazlis & Rivas, will interrogate the success of both the EU’s plan and individual NCPs, with a focus on Greece’s policy. The one-day event will also introduce delegates to the latest advances in cancer research and treatment and use case studies to highlight examples of best practice from throughout the region. The event will be held on March 7th 2025 in Athens, Greece. It will bring together leading experts, policymakers, doctors, patient groups and other stakeholders to discuss topics critical to the future of cancer care, including:

• Assessing the effectiveness of the latest cancer plans published by the EU and Greece
• Studying the latest science enabling the early diagnosis of cancer
• Analysing the value of cancer prevention policies
• Identifying the latest innovations in research, treatment and care
• Imagining the future of cancer including clinical research and cutting-edge therapies

Under the scientific auspices of                        Under the auspices of                          Supported by